# McKesson Ventures

McKesson Ventures is a Venture Capital based in San Francisco, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** ventures.mckesson.com
- **LinkedIn:** https://www.linkedin.com/company/mckesson-ventures

## Regulatory record

- **Reports private funds:** No

## About

McKesson Ventures helps entrepreneurs and seasoned teams build and scale businesses that tackle some of the toughest challenges in healthcare. The firm invests in venture and growth stage companies that build innovative software and services for the healthcare and pharma industries. It has deep healthcare experience as investors and operators and brings the expertise and connections of McKesson, one of the largest healthcare companies in the world, to help its portfolio companies succeed.

## Sectors

- Digital Health
- Healthcare Services
- Pharma Tech Services
- Health-Tech & Tech Enabled Services

## People

- Dave Schulte — President
- Tom Rodgers — EVP, Chief Strategy Officer
- Jennifer Carter — Partner & VP Venture Operations
- Peter Lafer — Partner, Head of Growth Equity
- Michelle Snyder — Partner, Venture
- Carrie Hurwitz Williams — Partner, Venture

## Questions

### How does McKesson Ventures differ from a standard corporate venture capital arm?

McKesson Ventures operates as a dedicated platform team that actively bridges portfolio companies into the parent corporation's commercial operations. The team helps startups access McKesson's provider, payor, and pharmacy networks rather than acting as a passive balance-sheet investor. This creates a structural advantage where portfolio companies can scale through existing distribution channels that touch roughly one-third of U.S. cancer patients and a significant share of American medicines, according to the firm's website.

### What is the relationship between McKesson Ventures and McKesson Corporation?

McKesson Ventures is wholly owned and funded by McKesson Corporation, a healthcare distribution and services company with over $400 billion in annual revenue. Tom Rodgers, who founded the unit in 2014, now serves as EVP and Chief Strategy Officer of the parent company and continues to oversee the Ventures program and its investment committee. This direct C-suite linkage ensures strategic alignment between the venture portfolio and McKesson's broader corporate objectives.

### Does McKesson Ventures invest in both venture and growth equity?

Yes. The firm maintains a dual-stage mandate. The Venture group, led by Partners including Michelle Snyder, Carrie Hurwitz Williams, and Jennifer Carter, targets early-stage and startup companies. The Growth Equity group, led by Partner Peter Lafer, focuses on later-stage businesses. The portfolio includes confirmed positions in clinical-trial technology company Saama and value-based primary-care network Aledade, reflecting the range of stages the firm covers.

### Who runs investment decisions at McKesson Ventures?

President Dave Schulte leads the investment team and manages day-to-day operations. The investment committee is overseen by Tom Rodgers, McKesson's EVP and Chief Strategy Officer. Individual Partners manage active portfolios: Schulte's active investments include Aledade, Clinical Ink, Komodo, and Saama, while Michelle Snyder's include CancerIQ, Midi Health, and RxVantage, among others.

### Which sectors does McKesson Ventures target?

The firm organizes its portfolio into two main sectors: Pharma Tech Services and Health-Tech & Tech Enabled Services. Pharma Tech includes companies that provide software, data analytics, and clinical-trial services to pharmaceutical firms — examples include Aetion and Clinical Ink. Health-Tech focuses on care-delivery models and workflow tools, with portfolio companies such as Aledade (value-based primary care) and IVX Health (infusion centers).

### How is McKesson Ventures structurally connected to the parent company's operational businesses?

The Ventures unit maintains a dedicated Platform and Insights team that evaluates synergies between portfolio companies and McKesson's operating units. Jennifer Carter, Partner & VP Venture Operations, leads efforts to identify and activate commercial connections within McKesson's pharmacy, oncology, and medical-surgical distribution networks — effectively serving as a bridge between early-stage innovation and scaled distribution.

## Related profiles

- [McKesson (US) Pension Plan](https://altss.com/profile/mckesson-us-pension-plan)
- [McKinley Management](https://altss.com/profile/mckinley-management)

---

Last updated: 2026-08-11T15:07:26.757Z

Canonical page: https://altss.com/profile/mckesson-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology